Yonhap NewsEN
LG Chem revises licensing deal with U.S. firm for obesity drug
SEOUL, Nov. 3 (Yonhap) -- LG Chem Ltd., South Korea's leading chemical company, ...
🇺🇸 United States / English
The world, in perspective.
Fresh headlines from around the world. Gaming, politics, technology and everything in between.
The Guardian PoliticsEN
UK government’s obesity plan ‘doomed to fail’, MPs warn
<p>Cross-party committee says ‘moonshot’ vow to end obesity epidemic in a decade will fail without personal leadership from PM</p><p>The UK government’s promise to reverse rising obesity rates in the next decade is “doomed to fail” without a major rethink and a new plan led directly by the prime minister, a cross-party committee of MPs has concluded.</p><p>T
CNBCEN
We're raising our price target on Eli Lilly as the obesity-drug boom rolls on
The Lilly train keeps on rolling thanks to Mounjaro and Zepbound. And there's more growth to be had.
CNBCEN
Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
The Irish TimesEN
Regulation of food industry is needed to tackle obesity
Drugs like Mounjaro are not the only solution to problem
Allnira republishes accessible articles under owner-declared permissions, with original authors, publishers and image credits. Automatic cloud imports run hourly; open pages check for updates every 15 seconds. Publication delays depend on each feed.